Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Medicure (MCUJF) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Medicure (MCUJF) over the last 16 years, with Q3 2025 value amounting to -$377030.1.

  • Medicure's Cash from Operations rose 3320.41% to -$377030.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 3528763.55%. This contributed to the annual value of $985724.3 for FY2024, which is 3545.12% down from last year.
  • Per Medicure's latest filing, its Cash from Operations stood at -$377030.1 for Q3 2025, which was up 3320.41% from -$526128.4 recorded in Q2 2025.
  • In the past 5 years, Medicure's Cash from Operations ranged from a high of $1.7 million in Q4 2021 and a low of -$581053.8 during Q1 2022
  • For the 5-year period, Medicure's Cash from Operations averaged around $390063.8, with its median value being $330262.3 (2021).
  • Over the last 5 years, Medicure's Cash from Operations had its largest YoY gain of 56670.28% in 2025, and its largest YoY loss of 229866.52% in 2025.
  • Over the past 5 years, Medicure's Cash from Operations (Quarter) stood at $1.7 million in 2021, then tumbled by 40.81% to $1.0 million in 2022, then plummeted by 33.18% to $680914.4 in 2023, then soared by 142.75% to $1.7 million in 2024, then crashed by 122.81% to -$377030.1 in 2025.
  • Its last three reported values are -$377030.1 in Q3 2025, -$526128.4 for Q2 2025, and $457177.2 during Q1 2025.